Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Regulus Therapeutics (RGLS)
Regulus Therapeutics (RGLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 26,693
  • Shares Outstanding, K 19,484
  • Annual Sales, $ 0 K
  • Annual Income, $ -28,320 K
  • 60-Month Beta 1.65
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.78
Trade RGLS with:

Options Overview Details

View History
  • Implied Volatility 166.99% ( -391.50%)
  • Historical Volatility 116.32%
  • IV Percentile 19%
  • IV Rank 6.34%
  • IV High 1,263.57% on 11/08/22
  • IV Low 92.76% on 11/04/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 148
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 9,033
  • Open Int (30-Day) 8,650

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate -0.36
  • Number of Estimates 1
  • High Estimate -0.36
  • Low Estimate -0.36
  • Prior Year -0.50
  • Growth Rate Est. (year over year) +28.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2400 +10.48%
on 09/22/23
1.8000 -23.89%
on 09/06/23
-0.3566 (-20.65%)
since 08/29/23
3-Month
1.2400 +10.48%
on 09/22/23
1.8499 -25.94%
on 08/29/23
-0.0600 (-4.20%)
since 06/29/23
52-Week
0.7600 +80.26%
on 03/20/23
2.1400 -35.98%
on 05/12/23
-0.3900 (-22.16%)
since 09/29/22

Most Recent Stories

More News
Regulus Therapeutics Announces Positive Topline Data from the First Cohort of Patients in its Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...

RGLS : 1.3700 (unch)
Regulus Therapeutics Announces Completion of Enrollment in Second Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)

/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...

RGLS : 1.3700 (unch)
Regulus Therapeutics Announces Participation at Two Healthcare Investment Conferences

/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...

RGLS : 1.3700 (unch)
Regulus: Q2 Earnings Snapshot

Regulus: Q2 Earnings Snapshot

RGLS : 1.3700 (unch)
Regulus Therapeutics Reports Second Quarter 2023 Financial Results and Recent Updates

/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...

RGLS : 1.3700 (unch)
Regulus Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference

/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...

RGLS : 1.3700 (unch)
Regulus Therapeutics to Present at the H.C. Wainwright 2nd Annual Kidney Conference

/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...

RGLS : 1.3700 (unch)
Regulus Therapeutics Announces Appointment of Preston S. Klassen, M.D. to its Board of Directors

/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...

RGLS : 1.3700 (unch)
Regulus Therapeutics Announces Update on Preclinical Studies in Amyotrophic Lateral Sclerosis in Collaboration with Researchers from Harvard's Brigham and Women's Hospital

/PRNewswire/ -- Regulus Therapeutics Inc (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting...

RGLS : 1.3700 (unch)
Regulus Therapeutics Strengthens Research & Development Leadership

/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...

RGLS : 1.3700 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs, called microRNA therapeutics. The Company's products aim to treat or prevent hepatitis C infections, cardiovascular disease, fibrosis, oncology, immuno-inflammatory diseases, and...

See More

Key Turning Points

3rd Resistance Point 1.4767
2nd Resistance Point 1.4433
1st Resistance Point 1.4067
Last Price 1.3700
1st Support Level 1.3367
2nd Support Level 1.3033
3rd Support Level 1.2667

See More

52-Week High 2.1400
Fibonacci 61.8% 1.6128
Fibonacci 50% 1.4500
Last Price 1.3700
Fibonacci 38.2% 1.2872
52-Week Low 0.7600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar